2015
DOI: 10.1134/s1607672915050087
|View full text |Cite
|
Sign up to set email alerts
|

Proteolysis of His-Phe-Arg-Trp-Pro-Gly-Pro in the blood and brain of rats in vivo

Abstract: The kinetics of the content of His-Phe-Arg-Trp-Pro-Gly-Pro (ACTH (6-9)PGP) and its hydrolysis products in the blood and brain of rats in the case of intranasal administration and intravenous injection of tritiated ACTH(6-9)PGP was studied. The parameters of bioavailability of ACTH(6-9)PGP administered intranasally were higher, indicating certain prospects in the intranasal application in clinical practice. We also found that the factor that determines ACTH(6-9)PGP proteolysis in experiments both in vivo and in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
3
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 3 publications
0
3
0
1
Order By: Relevance
“…The effects observed after peptide administration may be the result of the action of the pool of peptides—the initial peptide and the products of its proteolytic degradation (synacton) (Vyunova et al, 2016). As a result of proteolysis of the peptides studied, different derivatives are formed, which may cause differences in their effects (Shevchenko et al, 2015; Zolotarev et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The effects observed after peptide administration may be the result of the action of the pool of peptides—the initial peptide and the products of its proteolytic degradation (synacton) (Vyunova et al, 2016). As a result of proteolysis of the peptides studied, different derivatives are formed, which may cause differences in their effects (Shevchenko et al, 2015; Zolotarev et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…In the acute restraint stress model, we analyzed the delayed effect of peptides on the GABA‐receptor system, namely, after a sufficient time has elapsed for the peptide to reach its target in the brain, trigger cellular response processes and be destroyed by proteolytic enzymes. It was shown earlier that the peptides studied are able to entry into the brain after systemic administration, amount of the peptides in the brain reached its maximum in several minutes after injection, and then diminished at 1–2 h (Potaman et al, 1991; Shevchenko et al, 2014, 2015).…”
Section: Introductionmentioning
confidence: 89%
“…В основе центрального действия пептида могут находиться следующие механизмы. Так, АКТГ 6-9 -ПГП мог снижать активность гипоталамо-гипофизарно-надпочечниковой оси путем взаимодействия с центральными меланокортиновыми рецепторами вследствие его способности проникать через гематоэнцефалический барьер [19]. Данное обстоятельство может обусловить снижение секреции КРФ в гипоталамусе и, следовательно, АКТГ и глюкокортикоидов.…”
Section: Discussionunclassified
“…The stability of ACTH(6–9)PGP and Semax is equivalent [ 19 ]. For both peptides, the ability to penetrate the blood-brain barrier and interact with brain structures has been established [ 20 , 21 , 22 ]. The polypeptide sequence of ACTH(6–9) is necessary and sufficient to activate most types of MC receptors [ 23 , 24 , 25 , 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%